Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
901.2 USD | +0.79% | -3.74% | +2.61% |
Apr. 17 | UBS Adjusts Regeneron Pharmaceuticals Price Target to $1,099 From $1,090, Maintains Buy Rating | MT |
Apr. 17 | The market is pinning its hopes on earnings reports |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.